GALVESTON, Texas--(BUSINESS WIRE)--Chrysalis BioTherapeutics, Inc. announced today that the US Food and Drug Administration (FDA) has given the company permission to initiate human clinical trials aimed at treating acute lung…
GALVESTON An island biopharmaceutical company has received U.S. Food and Drug Administration clearance for its first ever human tests of a drug to treat a potentially fatal lung condition that…
We answer all email and requests as they come in. If you have an urgent matter or would like to place an order please click the link below to give us a call.
Chrysalis BioTherapeutics, Inc. is committed to helping improve people’s lives through innovation.